A Safety Study of LY3372689 in Healthy Participants
Condition(s):HealthyLast Updated:April 24, 2020Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:April 24, 2020Completed
Condition(s):Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Cancer; Melanoma; Advanced Solid Tumor, Adult; Metastatic Castrate Resistant Prostate Cancer; Non Small Cell Lung CancerLast Updated:February 7, 2024Terminated
Condition(s):Type 2 Diabetes MellitusLast Updated:April 25, 2022Completed
Condition(s):Non-small Cell Lung Cancer AdenocarcinomaLast Updated:February 21, 2021Terminated
Condition(s):LeukemiaLast Updated:November 30, 2011Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:October 7, 2015Completed
Condition(s):Autoimmune DiseasesLast Updated:June 27, 2017Completed
Condition(s):Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative NeoplasmsLast Updated:July 18, 2013Completed
Condition(s):Advanced Solid TumorsLast Updated:October 30, 2023Active, not recruiting
Condition(s):add-on Maintenance Treatment of Patients With Severe Eosinophilic AsthmaLast Updated:January 28, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.